SJS Investment Consulting Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1894302 SYLVANIA, OH

Position in GILD

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$86,036

-$8,595 QoQ

Shares Held

681

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#2,010

of 2,266 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $25,886,295 across 14 Drug Manufacturers - General names. GILD ranks #9 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	19,153	$22,972,684
2	JNJ	Johnson & Johnson	4,507	$1,144,642
3	ABBV	AbbVie Inc.	1,943	$488,936
4	NVS	Novartis AG	1,839	$288,207
5	MRK	Merck & Co., Inc.	1,992	$255,972
6	AMGN	Amgen Inc	657	$237,912
7	BMY	Bristol Myers Squibb Co	2,963	$170,728
8	PFE	Pfizer Inc	5,482	$132,005

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$86,036	681	+0.3%	Shares	Sole	2026-07-22
2026-03-31	$94,631	679	+84.5%	Shares	Sole	2026-04-23
2025-12-31	$45,167	368	-25.2%	Shares	Sole	2026-01-21
2025-09-30	$54,612	492	+213.4%	Shares	Sole	2025-10-21
2025-06-30	$17,406	157	-80.2%	Shares	Sole	2025-07-15
2025-03-31	$88,743	792	+0.5%	Shares	Sole	2025-04-15
2024-12-31	$72,787	788	+266.5%	Shares	Sole	2025-01-21
2024-09-30	$18,024	215	+1.9%	Shares	Sole	2024-10-16
2024-06-30	$14,476	211	-7.5%	Shares	Sole	2024-07-16
2024-03-31	$16,701	228	+68.9%	Shares	Sole	2024-04-18
2023-12-31	$10,936	135	-14.0%	Shares	Sole	2024-01-16
2023-09-30	$11,764	157	+33.1%	Shares	Sole	2023-10-17
2023-06-30	$9,093	118	-70.7%	Shares	Sole	2023-07-13
2023-03-31	$33,436	403	+187.9%	Shares	Sole	2023-04-20
2022-12-31	$12,018	140	+42.9%	Shares	Sole	2023-01-23
2022-09-30	$6,045	98	+58.1%	Shares	Sole	2022-10-13
2022-03-31	$3,685	62	+87.9%	Shares	Sole	2022-05-05
2021-12-31	$2,396	33	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.